797 Real-world treatment duration of atezolizumab+carboplatin+etoposide among older patients with extensive-stage small cell lung cancer (ES-SCLC) and the impact of performance status and brain metastases
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.